Scatter factor protein levels in human breast cancers: Clinicopathological and biological correlations

American Journal of Pathology

Volumn 149, Issue 5, 1996, Pages 1707-1717

  Yao, Yan ^a   Jin, Liang ^a   Fuchs, Alexander ^a   Joseph, Ansamma ^a   Hastings, Harold M ^b   Goldberg, Itzhak D ^a   Rosen, Eliot M ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b HOFSTRA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR; VON WILLEBRAND FACTOR;

ARTICLE; BREAST CANCER; CANCER INVASION; CELL CYCLE S PHASE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MORPHOGENESIS; PLOIDY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTO ONCOGENE;

BREAST NEOPLASMS; CARCINOMA; DNA, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-1; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VON WILLEBRAND FACTOR;

EID: 0029948303     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Stoker M, Gherardi E, Perryman M, Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987, 327:238-242
2. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 1989, 342:440-443
3. Rosen EM, Nigam SK, Goldberg ID: Scatter factor and the c-met receptor a paradigm for mesenchymal: epithelial interaction. J Cell Biol 1994, 127:1783-1787
4. Yoshimura T, Yuhki N, Wang MH, Skeel A, Leonard EJ: Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J Biol Chem 1993, 268:15461-15468
5. Rosen EM, Meromsky L, Setter E, Vinter DW, Goldberg ID: Smooth muscle-derived factor stimulates mobility of human tumor cells. Invasion Metastasis 1990, 10: 49-64
6. Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W: Scatter factor: molecular characteristics and effect on invasiveness of epithelial cells. J Cell Biol 1990, 111:2097-2108
7. Rosen EM, Goldberg ID, Liu D, Setter E, Donovan MA, Bhargava M, Reiss M, Kacinski BM: Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res 1991, 57:5315-5321
8. Rosen EM, Knesel J, Goldberg ID, Bhargava M, Joseph A, Zitnik R, Wines J, Kelley M, Rockwell S: Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor, Int J Cancer 1994, 57:706-714
9. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991, 251:802-804
10. Grant DS, Kleinman HK, Goldberg ID, Bhargava M, Nickoloff BJ, Polverini P, Rosen EM: Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993, 90:1937-1941
11. Naidu YM, Rosen EM, Zitnik R, Goldberg I, Park M, Naujokas M, Polverini PJ, Nickoloff BJ: Role of scatter factor in the pathogenesis of AIDS-related Kaposi's sarcoma. Proc Natl Acad Sci USA 1994, 91:5281-5285
12. Rong S, Bodescot M, Blair D, Dunn J, Nakamura T, Mizuno K, Park M, Chan A, Aaronson S, vande Woude GF: Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol 1992, 12:5152-5158
13. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T, Sadahito S: Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 1994, 54:1630-1633
14. Joseph A, Weiss GH, Jin L, Fuchs A, Chowdhury S, O'Shaughnessy P, Goldberg ID, Rosen EM: Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst 1995, 87:372-377
15. Rosen EM, Joseph A, Jin L, Rockwell S, Elias JA, Knesel J, Wines J, McClellan J, Kluger MJ, Goldberg I, Zitnik R: Regulation of scatter factor production via a soluble inducing factor. J Cell Biol 1994, 127:225-234
16. Bhargava MM, Joseph A, Li Y, Pang S, Goldberg I, Setter E, Donovan MA, Zarnegar R, Michalopoulos GA, Nakamura T, Rosen EM: Scatter factor and hepatocyte growth factor: comparison of biological activities and immunologic reactivity. Cell Growth Differ 1992, 3:11-20
17. Bahn AK: Basic Medical Statistics. New York, Grune and Stratton, 1972, 260 pp
18. Fentiman IS: The treatment of in situ breast cancer. Acta Oncol 1989, 28:923-926
19. Fisher ER: Prognostic and therapeutic significance of pathologic features of breast cancer. Natl Cancer Inst Monogr 1986, 1:29-34
20. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989, 63:181-187
21. Fisher B, Redmond CK, Wickerham DL, Rockette HE, Brown A, Allegra J, Bowman D, Plotkin D, Wolter J: Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy. Breast Cancer Res Treat 1983, 3:355-364
22. Fisher B, Gunduz N, Costantino J, Fisher ER, Redmond C, Mamounas EP, Siderits R: DNA flow cytometric analysis of primary operable breast cancer: relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04. Cancer 1991, 68:1465-1475
23. Le Doussal V, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos P, Brunet M: Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR): an improved score modification based on multivanate analysis of 1262 invasive breast carcinomas. Cancer 1989, 64:1914-1921
24. Jones TR, Kao KJ, Pizzo SV, Bigner DD: Endothelial cell surface expression and binding of factor VIII/von Willebrand factor. Am J Pathol 1981, 103:304-308
25. Tamura M, Arakaki N, Tsoubouchi H, Takada H, Daikuhara Y: Enhancement of human hepatocyte growth factor production by interleukin-1α and -1β and tumor necrosis factor-α by fibroblasts in culture. J Biol Chem 1993, 268:8140-8145
26. Ben Av P, Crofford LJ, Wilder RL, Hla T: Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 1995, 372:83-87
27. Fan TP, Hu DE, Guard S, Gresham GA, Watling KJ: Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol 1993, 110: 43-49
28. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8
29. Weidner N, Folkman J, Pozza F, Bevilaqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 1992, 84:1875-1887
30. Toi M, Kashitani J, Tominaga T: Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993, 55:371-374
31. Axelsson K, Ljung BE, Moore DH II, Thor AD, Chew KL, Edgerton SM, Smith HS, Mayall BH: Tumor angiogenesis as a prognostic assay for invasive breast carcinoma. J Natl Cancer Inst 1995, 87:997-1008
32. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992, 340:1120-1124
33. Brooks PC, Clark RA, Cheresh DA: Requirement of vascular integrin αvβ3 for angiogenesis. Science 1994, 264:569-571